Latest Vimta Labs stock price
Vimta Labs P/E Ratio
VIMTALABS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
44.9
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
44.9
Current Price
₹602.15
EPS (TTM)
₹18.51
Exchange
NSE
Valuation Signal
Signal
Overvalued
Historical Avg
8.62
Historical Range
5.16 - 12.24
Percentile
100.0%
Sector Context
Sector Average
57.47
Sector Median
35.38
Sector Rank
#11 of 88
Sector Percentile
12.5%
Earnings Breakdown (TTM)
TTM EPS
₹27.65
Sept 2024
₹6.88
Mar 2024
₹5.58
Key P/E Ratio Insights for Vimta Labs
- Stock appears overvalued with PE of 44.9, suggesting caution for new investments
- Current PE is 420.7% above historical average
- Trading at discount to sector average PE of 57.47
View the VIMTALABS equity price for detailed stock performance.
P/E Ratio Historical Trend for Vimta Labs
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for Vimta Labs
Additional stock information and data for VIMTALABS
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 7.33 | 27.65 | ₹202.65 | NSE | Low |
| 2023 | 12.24 | 17.71 | ₹216.85 | NSE | Low |
| 2022 | 9.76 | 21.4 | ₹208.85 | NSE | Low |
| 2021 | 5.16 | 16.84 | ₹86.95 | NSE | Low |
Sector P/E Ratio Comparison
Comparing Vimta Labs with other companies in Healthcare sector
Sector Average
57.47
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |
| Lincoln Pharmaceuticals | LINCOLN | 12.02 | ₹974 | Low |
| QMS Medical Allied Servi… | QMSMEDI | 12.82 | ₹177 | Low |
| Take Solutions | TAKE | 13.15 | ₹638 | Low |
| Venus Remedies | VENUSREM | 14.27 | ₹995 | Low |
| Royal Sense | ROYAL | 14.5 | ₹96 | Low |
| Bliss GVS Pharma | BLISSGVS | 16.62 | ₹1,973 | Moderate |
| RPG Life Sciences | RPGLIFE | 17.94 | ₹3,861 | Moderate |